Mylan’s EpiPen is used as a lifesaver to threatening allergic reactions. It mitigates or reverses allergic reactions including abrupt blocking of airways and swollen legs, chest or neck. In late 2007, Mylan acquired the rights to sell EpiPen, an invention of the 1970s. Even its inventor Sheldon Kaplan did not know its real worth until Mylan hiked its price by 400% in 2016. The present cost of a two pen set has sky rocketed from $100 to $608, which is approximately a six fold increase in the price. This price hike is pushing patients backwards to conventional injections. Currently, around 63,000 people have signed a petition asking Congress to vet the rationality of th...